If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
80.78    0.90 (1.13%)
Bid:
80.50
Ask:
80.56
Spread: 0.06 (0.075%)
Market Cap: £2.81b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Directorate Change

20 May 2022 07:00

RNS Number : 1519M
Taylor Wimpey PLC
20 May 2022
 

20 May 2022

Taylor Wimpey plc

Board and Committee Changes

 

Taylor Wimpey plc is pleased to announce that Mark Castle and Clodagh Moriarty will be appointed as Independent Non Executive Directors with effect from 1 June 2022.

 

Mark Castle

 

Mark is a non executive director at Mace Group Ltd, a global consultancy and construction firm, and Eleco plc, an AIM listed digital solutions company supporting the built environment. Mark also recently became Non Executive Chairman of Triangle Group, the private equity backed fire safety business.

 

Mark has significant operational experience in all aspects of the construction sector. Until 2021 he was Chief Operating Officer of Mace Group Ltd and previously held executive roles at Structuretone Inc and Wates Group Ltd. In addition, Mark was chair of Build UK from 2017 to 2019.

 

On his appointment to the Board, Mark will also become a member of the Audit Committee and Nomination and Governance Committee.

 

Clodagh Moriarty

 

Clodagh is Retail and Digital Director at J Sainsbury PLC. She has 20 years of varied customer-focused experience across retail, strategy, digital transformation and e-commerce. Clodagh started her career at Bain & Company, Inc and since then, she has held a range of positions at J Sainsbury PLC, including Head of Strategy and Chief Digital Officer.

 

On her appointment to the Board, Clodagh will also become a member of the Nomination and Governance Committee.

 

Irene Dorner, Chairman said:

 

"On behalf of the Board, I am delighted to welcome Mark and Clodagh to the Board as Independent Non Executive Directors.

 

Mark's deep operational knowledge of the construction sector, with particular focus on supply chain, production and innovation, will augment the Board's current operational skill set and support the company's key priority areas, while Clodagh's strategic, digital and customer-focused experience will support our ongoing focus on delivering an enhanced experience for our customers.

 

I look forward to working with them both."

 

-Ends-

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 558323

Alice Black, Group General Counsel and Company Secretary

Debbie Archibald, Investor Relations

Finsbury TaylorWimpey-LON@FGH.com

Faeth Birch

Anjali Unnikrishnan

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAXKLFFLELEBBF
Date   Source Headline
1st Jul 20261:13 pmRNSTotal Voting Rights
12th Jun 20267:00 amRNSDirector/PDMR Shareholding
9th Jun 20263:11 pmRNSDirector/PDMR Shareholding
9th Jun 20267:00 amRNSDirectorate change
1st Jun 20267:00 amRNSTotal Voting Rights
20th May 202610:41 amRNSHolding(s) in Company
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20269:49 amRNSDirector/PDMR Shareholding
15th May 20261:32 pmRNSHolding(s) in Company
14th May 20267:00 amRNSTransaction in Own Shares
11th May 20264:10 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20263:30 pmRNSHolding(s) in Company
6th May 202611:05 amRNSHolding(s) in Company
5th May 202611:28 amRNSHolding(s) in Company
1st May 202611:53 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20264:34 pmRNSDirector/PDMR Shareholding
28th Apr 20264:23 pmRNSResult of AGM
28th Apr 20267:00 amRNSTrading Statement
23rd Apr 20269:25 amRNSTransaction in Own Shares
20th Apr 20268:41 amRNSDirector Declaration
16th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20263:42 pmRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20261:36 pmRNSTotal Voting Rights
30th Mar 20262:19 pmRNSHolding(s) in Company
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20263:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:22 pmRNSHolding(s) in Company
20th Mar 20263:37 pmRNSAnnual Financial Report and Notice of Meeting
19th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20263:23 pmRNSDirector/PDMR Shareholding
10th Mar 20263:23 pmRNSDirector/PDMR Shareholding
6th Mar 202611:44 amRNSDirector/PDMR Shareholding
5th Mar 20267:01 amRNSShare Buyback Programme
5th Mar 20267:00 amRNSTAYLOR WIMPEY PLC FULL YEAR RESULTS
2nd Mar 202611:50 amRNSTotal Voting Rights
10th Feb 20263:19 pmRNSDirector/PDMR Shareholding
2nd Feb 20262:17 pmRNSTotal Voting Rights
22nd Jan 20263:11 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSTrading Statement
9th Jan 20262:51 pmRNSDirector/PDMR Shareholding
2nd Jan 202612:02 pmRNSTotal Voting Rights
2nd Jan 202611:59 amRNSBlock listing Interim Review
2nd Jan 202611:54 amRNSBlock listing Interim Review
15th Dec 20254:17 pmRNSDirector/PDMR Shareholding
9th Dec 20254:21 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.